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Abstract
Purpose: Although common in children with tympanostomy tubes, the current incidence of tympanostomy tube otorrhea
(TTO) is uncertain. TTO is generally a sign of otitis media, when middle ear fluid drains through the tube. Predictors for otitis
media are therefore suggested to have predictive value for the occurrence of TTO.
Objective: To determine the incidence of TTO and its predictors.
Methods: We performed a cohort study, using a parental web-based questionnaire to retrospectively collect data on TTO
episodes and its potential predictors from children younger than 10 years of age with tympanostomy tubes.
Results: Of the 1,184 children included in analyses (total duration of time since tube placement was 768 person years with a
mean of 7.8 months per child), 616 children (52%) experienced one or more episodes of TTO. 137 children (12%) had TTO
within the calendar month of tube placement. 597 (50%) children had one or more acute TTO episodes (duration,4 weeks)
and 46 children (4%) one or more chronic TTO episodes (duration$4 weeks). 146 children (12%) experienced recurrent TTO
episodes. Accounting for time since tube placement, 67% of children developed one or more TTO episodes in the year
following tube placement. Young age, recurrent acute otitis media being the indication for tube placement, a recent history
of recurrent upper respiratory tract infections and the presence of older siblings were independently associated with the
future occurrence of TTO, and can therefore be seen as predictors for TTO.
Conclusions: Our survey confirms that otorrhea is a common sequela in children with tympanostomy tubes, which
occurrence can be predicted by age, medical history and presence of older siblings.
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Introduction
Tympanostomy tube placement is one of the most common
surgical procedures performed in children worldwide, with around
50,000 children in the Netherlands, and almost 700,000 in the
United States receiving tubes each year. [1,2] Indications for
tympanostomy tubes include prevention of acute otitis media
(AOM) recurrences in children with recurrent AOM and
restoration of hearing in children with persistent otitis media with
effusion (OME). [3] Tympanostomy tube otorrhea (TTO) is a
well-known and common sequela in children with tympanostomy
tubes. It is generally a sign of otitis media (OM), when middle ear
fluid drains through the tube. TTO can be accompanied by foul
odor, pain, and fever and can reduce the child’s quality of life. [4]
Moreover it may lead to blockage or early extrusion of the
tympanostomy tube and hence impact the child’s hearing. As
parents generally hope that tympanostomy tubes will solve their
child’s middle ear problems, they may be disappointed, or anxious,
when their child develops TTO. [5].
Published TTO incidences vary widely and the most recent
publications on this topic date from 2001. In that year, a meta-
analysis reported an average TTO incidence of 26% based on 23
studies with incidences ranging from 4% up to 68%. [6] A
subsequent trial reported a TTO incidence of 75% at 12 months
after tube placement in children younger than 3 years. [7]
Irrespective of the wide range of reported incidences, changes in
health care practice over the last decade, such as development of
new OM guidelines and the introduction of pneumococcal
vaccination in children, may have changed the incidence of TTO.
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For OM, many risk factors have been established such as age,
gender, day-care attendance and household smoking. [8,9] These
factors have also been suggested to have predictive value for the
occurrence of TTO, but evidence is limited. [10] In addition, the
indication for tympanostomy tube placement and frequent water
exposure of the ear during swimming or bathing, have been
considered as predictors specific for TTO occurrence. [10].
The objectives of the current study are to establish the incidence
of TTO in children aged up to 10 years of age with tympanostomy
tubes, and to identify predictors for TTO in these children.
Methods
We designed a cohort study, using a web-based survey to
retrospectively collect data on TTO at one point in time from
children with tympanostomy tubes. Approval from the Medical
Ethics Committee of the University Medical Center Utrecht was
obtained.
Population Characteristics
The survey was conducted among a cohort of 3,559 children up
to 10 years of age. They had tympanostomy tubes placed between
April 2009 and June 2011 in 18 Dutch general hospitals and two
academic hospitals. Children were excluded from the current
survey if they had Down’s syndrome, a known immune disorder,
cleft lip or palate or if their questionnaire was filled out
incompletely.
Data Collection
Between May and October 2011, a letter was sent to the parents
of the children asking them to participate in the survey by filling
out a web-based questionnaire regarding potential TTO predic-
tors at the time of the most recent tube placement, TTO
occurrence thereafter and time of extrusion of the tympanostomy
tube(s) (Appendix S1 and S2). The standardized questionnaire was
piloted in a small group of parents of children with tympanostomy
tubes and amended based on their responses. It could be filled out
at only one point in time. A reminder was sent to the parents who
did not complete the questionnaire within 6 weeks after sending
the letter.
All children remained under the care of their own family
physician and ENT physician throughout our survey. We asked
parents if they were willing to fill out a web-based questionnaire
and did not attempt to alter local care pathways.
Data-analysis
We used Rothman’s Episheet (version October 2011) to
calculate the incidences. [11] For all other statistical analyses we
used SPSS version 17 (SPSS Inc., Chicago, Ill).
Time since tympanostomy tube placement. Time since
tympanostomy tube placement was defined as starting at the day
of the most recent tube placement and ending at the day the web-
based questionnaire was filled out. We censored this time period
either at the date of tube extrusion as reported by the parents or,
when parents were uncertain about presence of tympanostomy
tubes, at the day the tubes were last seen in place by a physician.
We included all reported TTO episodes during this time period in
our analyses.
Incidence. We calculated the number of children who had
developed 1 or more TTO episodes. Moreover, we assessed the
number of children with 2 to 3, or 4 or more episodes of TTO, the
numbers of children with early TTO (starting within the calendar
month of tube placement), acute TTO (duration ,4 weeks),
chronic TTO (duration $4 weeks) and recurrent TTO ($3
episodes in 6 months or $4 episodes in 12 months), and the
proportions of TTO episodes managed by antibiotic(-steroid)
eardrops, oral antibiotics or initial observation.
To account for differences in time since tube placement, we
assessed incidence densities. We used a Kaplan-Meier curve to
depict the time between tube placement and the occurrence of a
first TTO episode in the first 12 months after tube placement. We
also assessed the median duration between the most recent tube
placement and onset of the first TTO episode in children
developing TTO, and the TTO incidence rate in all included
children.
Predictors. We selected candidate predictors based on their
suggested or shown association with OM or TTO in the literature
(see table 1 for definitions).[7–10,12–15,17,18] First, we assessed
the relation between each of the candidate predictors and our
main outcome (one or more episodes of TTO in the time period
since tympanostomy tube placement). To account for differences
in time since tube placement we used Cox regression analyses
using occurrence of the first TTO episode as the outcome. Second,
to determine independent predictors, we also performed a
multivariable Cox regression analysis. For this analysis, we did
not select predictors based on the outcomes of univariable
analyses, but included all putative indicators, and used a backward
elimination procedure with a cutoff value of p,0.05 to identify
independent predictors. In this, we followed the rule of thumb of a
minimum of 10 events for each predictor to be included in the
multivariable Cox regression analysis. [16] All results were
expressed as hazard ratios (HR) with 95% confidence intervals
(CI). We dichotomized age (,4 years/$4 years) for the
univariable analysis, but because of potential loss of information
we included age as a continuous variable in the multivariable
analysis. Guided by the outcomes of the multivariable Cox
regression analysis, we calculated the absolute risk (incidence) of
TTO in children grouped according to the presence of the
independent predictors.
Results
Parents of 3,559 children who had tympanostomy tubes placed
by their local ENT physician were approached and between May
and December 2011 we received questionnaires of 1,322 (37%)
children (Appendix S3). Of these 1,322 children, we excluded 138
from analysis: 9 with cleft lip or palate, 4 with a known
immunodeficiency, 4 with Down’s syndrome, 109 whose ques-
tionnaires were not completed and 12 children whose parents had
reported incorrect dates making it impossible to calculate the time
period since tympanostomy tube placement.
At tube placement, the mean age of the 1,184 included children
was 4.4 years (SD: 2.3) and 58% were boys. The total time
between tube placement and the survey was 768 person years with
a mean of 7.8 months (SD: 5.7, range: 0.3 to 34.0) and a median of
6.4 months (interquartile range: 7.9) per child. Other baseline
characteristics of the included children are presented in table 1.
Incidence
A total of 616 (52.0%) of the children experienced one or more
episodes of TTO (table 2). 137 children (11.6%) had otorrhea
within the calendar month of tube placement. 597 (50.4%)
children had one or more acute TTO episodes with a duration
below 4 weeks and 46 (3.9%) one or more chronic TTO episodes
(duration $4 weeks). 146 (12.3%) of the children experienced
recurrent episodes of TTO. 60.5% of the reported TTO episodes
had been treated with antibiotic(-steroid) eardrops, 12.9% with
oral antibiotics and 36.1% had been managed with initial
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observation (total exceeds 100% because treatments are not
mutually exclusive).
Figure 1 shows the Kaplan-Meier curve of the time between
tube placement and the occurrence of a first TTO episode. It
demonstrates that at 6 months, 49.1% of the children had
developed one or more episodes of TTO. At 12 months this
percentage is 67.2%. In the children who experienced TTO, the
median time between tube placement and onset of the first episode
was 2 months (interquartile range: 3). The TTO incidence rate in
our study population was 1.8 (95% CI: 1.7 to 1.9) episodes per
person year.
Predictors
The results of the univariable analyses are presented in table 1.
When accounted for differences in time since tympanostomy tube
placement and dependency between predictors, age (per year
increase: HR=0.95; 95% CI: 0.91 to 0.98), the indication for tube
placement being recurrent acute OM (HR=1.26; 95% CI: 1.06 to
1.49), a history of 6 or more upper respiratory tract infections in
the past year (HR=1.38; 95% CI: 1.17 to 1.63) and having older
siblings (HR=1.21; 95% CI: 1.03 to 1.42) were found to be
independent predictors for the occurrence of otorrhea in children
with tympanostomy tubes (see table 1). Table 3 gives an indication
of the risk (incidence) of TTO in children according to the
presence of these independent predictors (except age): the risk of
TTO ranged from 38.1% in children without any of these
predictors up to 67.5% in children with all predictors present at
tympanostomy tube placement.
Table 1. Univariable and multivariable Cox regression analysis of potential predictors for developing otorrhea in children with
tympanostomy tubes.
Potential predictors $1 episode of TTO, n (%) Univariable Multivariable
i
Yes (n =616) No (n =568) HR (95% CI) HR (95% CI) Coefficient (SE)
Age ,4 years 305 (49.5) 201 (35.4) 1.00 – –
$4 years 311 (50.5) 367 (64.6) 0.72 (0.62; 0.85) – –
Age per year increase – – 0.91 (0.87; 0.94) 0.95 (0.91; 0.98) 20.06 (0.02)
Male gender 360 (58.4) 325 (57.2) 1.08 (0.92; 1.27) NS NA
Indication for tube
placementii
Recurrent acute otitis media 319 (51.8) 204 (35.9) 1.48 (1.26; 1.73) 1.26 (1.06; 1.49) 0.23 (0.09)
Chronic otitis media with
effusion
291 (47.2) 356 (62.7) 0.69 (0.59; 0.80) NS NA
Previous tube placement 228 (37.0) 281 (49.5) 0.83 (0.70; 0.97) NS NA
Previous ENT surgery Adenoidectomy 347 (56.3) 279 (49.1) 1.22 (1.04; 1.44) NS NA
Tonsillectomy 130 (21.1) 121 (21.3) 0.99 (0.81; 1.20) NS NA
$6 URTIs in past year 282 (45.8) 183 (32.2) 1.59 (1.35; 1.86) 1.38 (1.17; 1.63) 0.32 (0.09)
Atopyiii 199 (32.3) 152 (26.8) 1.12 (0.95; 1.33) NS NA
Water exposure 430 (69.8) 415 (73.1) 0.83 (0.70; 0.99) NS NA
Attending day-care/schooliv 282 (92.5) 190 (94.5) 0.79 (0.51; 1.20) NS NA
Smoking in household 32 (5.2) 33 (5.8) 0.91 (0.64; 1.30) NS NA
Low maternal education level 65 (10.6) 55 (9.7) 1.09 (0.84; 1.41) NS NA
Overweightv 38 (6.2) 36 (6.3) 0.94 (0.68; 1.31) NS NA
$2 siblings 200 (32.5) 172 (30.3) 1.06 (0.90; 1.26) NS NA
Older siblings 363 (58.9) 285 (50.2) 1.29 (1.10; 1.51) 1.21 (1.03; 1.42) 0.19 (0.08)
Family history Middle ear infections in
parents
303 (49.2) 280 (49.3) 1.10 (0.94; 1.29) NS NA
Middle ear infections in
siblingsvi
231 (44.0) 241 (46.5) 1.03 (0.86; 1.22) NS NA
Allergy in parents 324 (52.6) 325 (57.2) 0.92 (0.78; 1.07) NS NA
Allergy in siblingsvi 168 (32.0) 152 (29.4) 1.08 (0.90; 1.30) NS NA
Gestational age ,37 weeks 75 (12.2) 68 (12.0) 0.99 (0.78; 1.26) NS NA
Birth weight ,2500 grams 44 (7.1) 41 (7.2) 1.09 (0.80; 1.48) NS NA
Breastfed for .3 months 305 (49.5) 277 (48.8) 0.97 (0.83; 1.13) NS NA
Pacifier use in previous year 133 (21.6) 79 (13.9) 1.43 (1.18; 1.73) NS NA
PCV7-vaccination 339 (55.0) 251 (44.2) 1.42 (1.21; 1.67) NS NA
TTO= tympanostomy tube otorrhea; n = number; HR = hazard ratio; CI = confidence interval; SE = standard error; i = only results presented for independent predictors
with p,0.05; NS = not significant; NA=not applicable; ii = 14 children for other indications; ENT = ear, nose and throat; URTI = upper respiratory tract infection;
iii = diagnosis of allergic rhinitis, asthma, eczema or food allergy; iv = univariable analysis only including children younger than 4 years, school is mandatory for children 4
years and over; v = BMI was categorized into underweight or normal weight versus overweight according to the World Health Organization standards, corrected for age
and gender. [24,25]; vi = univariable analysis only including 1045 children with siblings; PCV-7 = 7-valent pneumococcal vaccine.
doi:10.1371/journal.pone.0069062.t001
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Discussion
In this cohort study of children younger than 10 years of age
with tympanostomy tubes, 67% experienced one or more episodes
of otorrhea in the year after tube placement. Young age, recurrent
acute OM being the indication for tube placement, a recent
history of recurrent upper respiratory tract infections and the
presence of older siblings are independently associated with the
future occurrence of TTO.
This is one of the largest studies on the incidence of TTO. The
TTO incidence ascertained in our survey is higher than reported
by Kay et al. in 2001. [6] In their meta-analysis they found a wide
range of incidences as reported in the different studies, which they
explained by differences in study design. In our population 22% of
parents contacted the ENT physician, and 17% their family
physician every time their child developed TTO (data not shown).
This indicates that observational studies relying on medical
records are likely to underreport TTO incidence. Clinical trials
on the other hand report much higher TTO incidences, as they
may include asymptomatic and subclinical episodes. [7] We
believe that our parent-reported observational study provides a
good estimate of the TTO incidence in children with tympanos-
tomy tubes.
To our knowledge, this is the first study establishing the
associations between a comprehensive set of potential predictors
and future occurrence of TTO. Previous studies on these
associations often used univariable analyses or included a small
selection of predictors.[7,12–14,17,18] To account for dependen-
cies between predictors, we have performed a multivariable
analysis. Because all included children have a history of OM, the
absolute hazard ratios, which can also be interpreted as relative
risks, are small. The TTO incidence is however considerably
higher in children with more independent predictors present at the
time of tube placement than those with fewer of these predictors.
Our results are consistent with those of Debruyne et al. who
labeled age and a history of recurrent acute OM as predictors for
TTO, and those of Gates et al. who suggested an association
between recurrent upper respiratory tract infections and the
occurrence of TTO. [13,14] A potential TTO-specific predictor is
frequent water exposure by bathing or swimming; we however did
not find any association. Although pneumococcal vaccination was
believed to reduce OM incidence, a recent review suggests that its
effect on OM incidence is only marginal. [9,10,19] A first glance at
our univariable analysis suggests that pneumococcal vaccination
may increase the risk of a future occurrence of TTO, however this
is easily explained by the fact that all young children in our survey,
born since 2006 when pneumococcal vaccination was introduced
Table 2. Incidence of tympanostomy tube otorrhea.
Types of TTO* Children (n =1,184)
n % (95% CI)
Unspecified
1 or more episodes 616 52.0 (49.2; 54.9)
2 to 3 episodes 213 18.0 (15.9; 20.3)
4 or more episodes 102 8.6 (7.1; 10.3)
Early 137 11.6 (9.8; 13.5)
Acute 597 50.4 (47.6; 53.3)
Chronic 46 3.9 (2.9; 5.1)
Recurrent 146 12.3 (10.6; 14.3)
TTO= tympanostomy tube otorrhea; * Unspecified = any type of TTO,
early = starting within the calendar month of tube placement, acute = duration
,4 weeks, chronic = duration $4 weeks; recurrent =$3 episodes in 6 months
or $4 episodes in 12 months; n = number; CI = confidence interval.
doi:10.1371/journal.pone.0069062.t002
Figure 1. Kaplan-Meier curve for the duration between tube placement and the occurrence of a first TTO episode.
doi:10.1371/journal.pone.0069062.g001
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in The Netherlands, have been vaccinated and the older children
have not. Our multivariable analysis revealed no association
between pneumococcal vaccination and occurrence of TTO. The
surgical rate of tympanostomy tube placement is high in The
Netherlands, suggesting that our results may not be generalizable
to countries that have a different study domain through use of
more stringent criteria for tube placement. [20].
Some aspects of our study deserve further consideration. First,
we relied on parental diagnosis of TTO. We previously showed
that during follow-up after a physician diagnosis of otorrhea
(n = 291 children), there was a high level of agreement between
parents and physicians in the assessment of persisting ear
discharge. [21] Second, although so far no trials have assessed
the long-term effects of treatment for acute TTO, treatment may
influence persistence or recurrence of TTO. We therefore provide
information on the proportions of TTO episodes treated with
antibiotic(-steroid) eardrops, oral antibiotics and initial observation
and emphasize that throughout our survey children remained
under the care of their local family physician and ENT physician.
Third, non-response bias may have affected our results. We
explored this by comparing demographics, i.e. age and gender, of
responders and non-responders. In addition, we compared TTO
incidences as recorded in the medical records of a 10% sample of
all responders (n = 144) with those of an equal number of non-
responders. Although this does not rule out non-response bias, we
did not find differences between these groups for both comparisons
(data not shown). Fourth, we collected data on previous TTO
episodes using survey methods, whereby recall may have
contributed to inaccuracy of our incidence estimates. To address
this, we asked for the calendar month and year of TTO episodes
rather than the actual day of onset. Our study design therefore
allows us to approximate the incidence of early TTO, defined as
starting within the calendar month of tube placement. It does
however not allow us to determine the incidence of early
postoperative TTO, defined as starting within 2 weeks after tube
placement. Previous studies comparing parental report of OM
with diagnoses recorded in medical records have shown that OM
frequency is most prone to bias and the longer the time since OM
occurrence, the larger the inaccuracy of recall. [22,23] We
therefore used presence of one or more episodes of TTO as
outcome of our Cox regression analyses and Kaplan-Meier curve,
rather than the absolute number of episodes. Also, most children
in our survey had their tympanostomy tubes placed in the past
year, reducing the time since potential TTO occurrence. In
addition, as reported above we compared a random sample of
medical records with the completed questionnaires of these
children and checked the accuracy of verifiable data. We found
a high correspondence between the questionnaires and the
medical records with regard to patient characteristics, date and
number of tympanostomy tube placements and previous ENT
surgery (data not shown).
Conclusion
Our survey confirms that otorrhea is a common sequela in
children with tympanostomy tubes: more than half of these
children develop at least one episode, in particular young children
with older siblings, a recent history of recurrent upper respiratory
tract infections and recurrent acute otitis media being the
indication for tube placement.
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